Pretreatment integrase strand transfer inhibitor resistance in Tianjin, China-Reference-Cited by-同舟云学术

Pretreatment integrase strand transfer inhibitor resistance in Tianjin, China

Published:2023-11-03 Issue:22 Volume:136 Page:2735-2737
ISSN:0366-6999
Container-title:Chinese Medical Journal
language:en
Short-container-title:

Author:

Xia Huan¹,Ge Zhangwen²,Zhang Defa¹,Wu Yue¹,Ma Ping¹

Affiliation:

1. Department of Infectious Diseases, Tianjin Second People's Hospital, Tianjin 300192, China

2. Department of Laboratory Medicine, Guizhou Provincial People's Hospital, Affiliated Hospital of Guizhou University, Guiyang, Guizhou 550499, China.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

Reference18 articles.

1. Global, regional, and national incidence, prevalence, and mortality of HIV, 1980-2017, and forecasts to 2030, for 195 countries and territories: A systematic analysis for the Global Burden of Diseases, Injuries, and Risk Factors Study 2017;Lancet HIV,2019

2. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: A collaborative analysis of cohort studies;Lancet HIV,2017

3. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: A collaborative analysis of cohort studies;Trickey;Lancet HIV,2023

4. Sexual activity without condoms and risk of HIV transmission in serodifferent couples when the HIV-positive partner is using suppressive antiretroviral therapy;Rodger;JAMA,2016

5. Antiretroviral therapy for the prevention of HIV-1 transmission;Cohen;N Engl J Med,2016

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rapid Initiation of Antiretroviral Therapy Under the Treat-All Policy Reduces Loss to Follow-Up and Virological Failure in Routine Human Immunodeficiency Virus Care Settings in China: A Retrospective Cohort Study (2016–2022);AIDS Patient Care and STDs;2024-04-01